Citation Impact
Citing Papers
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Cisplatin therapy for adenocarcinoma of the stomach.
1991
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Gastric cancer
2016 Standout
Pathways mediating VEGF-independent tumor angiogenesis
2009
Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
2013
Post-remission therapy for acute myeloid leukemia
2014
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen
1998
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients
1998
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.
1988
Capecitabine
2001
Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes
1998
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine
2001
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
1993 Standout
VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis Formation
2009
The mechanisms of alloxan- and streptozotocin-induced diabetes
2007 Standout
Metabolism and action of amino acid analog anti-cancer agents
1990
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
1999
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Chemotherapy for advanced gastric cancer
2010
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Chemotherapy for advanced gastric cancer
2005
An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor
1996 StandoutNobel
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Pancreatic Adenocarcinoma
2014 Standout
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study
1995
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
1995
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
2009
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil
2006
Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.
1989
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
1997
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
1996
Immunity, Inflammation, and Cancer
2010 Standout
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
2003
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1994
DNA Methylation Inhibitors in the Treatment of Leukemias, Myelodysplastic Syndromes and Hemoglobinopathies: Clinical Results and Possible Mechanisms of Action
2000
Emerging Biological Principles of Metastasis
2017 Standout
Infectious and immunosuppressive complications of purine analog therapy.
1995
Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status
2000
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
1998
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
2011
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
1990 Standout
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
1997
Pancreatic Cancer
2010 Standout
Does tumour dormancy offer a therapeutic target?
2010
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 Standout
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
2009
Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study
2002
A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer
1991
Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
1993
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies
2009
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Evaluation of Two Consecutive Regimens in Advanced Gastric Cancer
1991
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Frontline Treatment of Advanced Gastric Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor (G-CSF)
2000
Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer
2000
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
1997
Chemotherapy of gastric cancer
1988
A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
1999
Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trial
1989
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Multiple Recurrent Genomic Defects in Follicular Lymphoma
1987
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin
2000
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
1985
Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma
1980
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
2006
Acute Myeloid Leukemia
2015 Standout
Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)
2002
Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial
2003
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil (Capecitabine, UFT, S-1): A Review
2002
Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma.
1987
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Chemotherapy for advanced gastric cancer
2017 Standout
Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update
1983
Wound recurrence following conventional treatment of colorectal cancer
1996
A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer
2004 Standout
Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
2009
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Mortality Associated With Irinotecan Plus Bolus Fluorouracil/Leucovorin: Summary Findings of an Independent Panel
2001
Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
2013
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
1997
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1991
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Adjuvant Therapy Of Soft-Tissue Sarcomas
1995
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
2010
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1995
High Doses of 5-Fluorouracil and Epirubicin with or without Cisplatin in Advanced Gastric Cancer: A Randomized Study
1999
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Adult acute myeloid leukaemia: update on treatment
1999
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
1989
An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
1987
Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.
1984
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
2002
Interferons, immunity and cancer immunoediting
2006
Works of M J O'Connell being referenced
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study
1993
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
1992
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.
1994
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study
1992
Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer.
1995
A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study
1989
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
1994
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
1997
A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
2009
Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.
1984
Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
1986
Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.
1984
A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
2009
Chemotherapy for Colorectal Carcinoma
1986
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
1986
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)
1974
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.
1992
Varying intensity of postremission therapy in acute myeloid leukemia
1992
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma.
1985
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
1976
A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
2009